Back
GDS Holdings Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
29
GDS
GDS Holdings
Last Price:
$19.84
Seasonality Move:
19.93%
Buy
54
SRPT
Sarepta Therapeutics
Last Price:
$53.93
Seasonality Move:
12.51%
Sell
29
GDS Holdings (GDS)
is a Sell
Is GDS Holdings a Buy, Sell or Hold?
-
The current GDS Holdings [GDS] share price is $20.63. The Score for GDS is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
GDS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $54.42. The Score for SRPT is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GDS Stock Price Chart
What is GDS Holdings's stock price today?
-
The GDS Holdings share price today is $20.63Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GDS is experiencing buying pressure, which is a positive indicator for future bullish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $54.42Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.
GDS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.28 | Sell |
Relative Strength Index (14 RSI): | 35.39 | Sell |
Chaikin Money Flow: | 493471 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -11.12 | Sell |
Relative Strength Index (14 RSI): | 31.94 | Sell |
Chaikin Money Flow: | -520094 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
GDS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 20.16 | Buy |
20-day SMA: | 24.18 | Sell |
50-day SMA: | 30.76 | Sell |
200-day SMA: | 21.26 | Sell |
8-day EMA: | 21.08 | Sell |
20-day EMA: | 24.22 | Sell |
50-day EMA: | 27.14 | Sell |
200-day EMA: | 22.38 | Sell |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 52.77 | Buy |
20-day SMA: | 63.08 | Sell |
50-day SMA: | 88.76 | Sell |
200-day SMA: | 119.57 | Sell |
8-day EMA: | 54.88 | Sell |
20-day EMA: | 64.14 | Sell |
50-day EMA: | 82.53 | Sell |
200-day EMA: | 109.32 | Sell |
GDS Holdings Earnings Growth & GDS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.37 per share, and an increase next year of $0.43 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.27 per share, a decrease next quarter of $0.11 per share, an increase this year of $3.98 per share, and an increase next year of $6.27 per share.
GDS Holdings Technical Analysis
Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |